Mind Medicine Inc [NASDAQ: MNMD] stock went on an upward path that rose over 3.72% on Thursday, amounting to a one-week price increase of more than 7.38%.
Over the last 12 months, MNMD stock rose by 92.39%. The one-year Mind Medicine Inc stock forecast points to a potential upside of 46.25. The average equity rating for MNMD stock is currently 1.08, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $1.02 billion, with 75.80 million shares outstanding and 72.58 million shares in the current float. Compared to the average trading volume of 1.50M shares, MNMD stock reached a trading volume of 5845419 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Mind Medicine Inc [MNMD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MNMD shares is $24.91 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MNMD stock is a recommendation set at 1.08. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Mind Medicine Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 13, 2025. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on August 04, 2025, representing the official price target for Mind Medicine Inc stock. Previously, the target price had yet another raise to $23, while Evercore ISI analysts kept a Outperform rating on MNMD stock.
The Price to Book ratio for the last quarter was 5.47, with the Price to Cash per share for the same quarter was set at 2.40.
MNMD Stock Performance Analysis:
Mind Medicine Inc [MNMD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.38. With this latest performance, MNMD shares gained by 8.60% in over the last four-week period, additionally plugging by 103.19% over the last 6 months – not to mention a rise of 92.39% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MNMD stock in for the last two-week period is set at 62.75, with the RSI for the last a single of trading hit 0.85, and the three-weeks RSI is set at 0.80 for Mind Medicine Inc [MNMD]. The present Moving Average for the last 50 days of trading for this stock 11.00, while it was recorded at 12.88 for the last single week of trading, and 8.27 for the last 200 days.
Mind Medicine Inc (MNMD) Capital Structure & Debt Analysis
According to recent financial data for Mind Medicine Inc. ( MNMD), the Return on Equity (ROE) stands at -59.11%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -42.95%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Mind Medicine Inc’s Return on Invested Capital (ROIC) is -50.54%, showcasing its effectiveness in deploying capital for earnings.
Mind Medicine Inc (MNMD) Efficiency & Liquidity Metrics
Based on Mind Medicine Inc’s (MNMD) latest financial statements, the Debt-to-Equity Ratio is 0.22%, indicating its reliance on debt financing relative to shareholder equity.
Mind Medicine Inc (MNMD) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Mind Medicine Inc. (MNMD) effectively leverages its workforce, generating an average of -$1547567.57 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.98% and a Quick Ratio of 4.98%, indicating strong ability to cover short-term liabilities.
MNMD Stock EPS
With the latest financial reports released by the company, Mind Medicine Inc posted -0.18/share EPS, while the average EPS was predicted by analysts to be reported at -0.26/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.08. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MNMD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Mind Medicine Inc go to -3.97%.
Mind Medicine Inc [MNMD] Institutonal Ownership Details
There are presently around $55.90%, or 56.35%% of MNMD stock, in the hands of institutional investors. The top three institutional holders of MNMD stocks are: COMMODORE CAPITAL LP with ownership of 7.15 million shares, which is approximately 9.9369%. DEEP TRACK CAPITAL, LP, holding 6.1 million shares of the stock with an approximate value of $$44.01 million in MNMD stocks shares; and DEEP TRACK CAPITAL, LP, currently with $$38.82 million in MNMD stock with ownership which is approximately 7.4869%.
